Reggiani, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.371
AS - Asia 1.279
EU - Europa 426
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 32
OC - Oceania 4
Totale 3.385
Nazione #
US - Stati Uniti d'America 1.323
SG - Singapore 709
CN - Cina 314
IT - Italia 191
BR - Brasile 136
VN - Vietnam 125
HK - Hong Kong 44
DE - Germania 30
FI - Finlandia 30
IE - Irlanda 29
IN - India 25
GB - Regno Unito 24
MK - Macedonia 21
CA - Canada 20
AR - Argentina 19
FR - Francia 19
MX - Messico 19
NL - Olanda 16
PL - Polonia 13
BD - Bangladesh 12
PH - Filippine 10
RU - Federazione Russa 8
ES - Italia 7
NG - Nigeria 7
UA - Ucraina 7
ZA - Sudafrica 7
EC - Ecuador 6
PK - Pakistan 6
AT - Austria 5
CO - Colombia 5
MA - Marocco 5
PE - Perù 5
TN - Tunisia 5
AU - Australia 4
CL - Cile 4
IQ - Iraq 4
LV - Lettonia 4
SA - Arabia Saudita 4
SE - Svezia 4
TR - Turchia 4
BB - Barbados 3
HU - Ungheria 3
JP - Giappone 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
ET - Etiopia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
LT - Lituania 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.293
Città #
Singapore 340
Ashburn 194
San Jose 186
Shanghai 119
The Dalles 96
Beijing 95
Council Bluffs 83
Boardman 72
Milan 68
Dallas 67
New York 52
Ho Chi Minh City 44
Santa Clara 44
Hong Kong 42
Los Angeles 37
Hanoi 31
Helsinki 30
Dublin 28
Chandler 26
Naples 25
Rome 25
Phoenix 17
Wilmington 17
São Paulo 14
Rio de Janeiro 10
Warsaw 10
Brooklyn 9
Orem 9
Skopje 9
Mexico City 8
Montreal 8
Paris 8
Washington 8
Amsterdam 7
Atlanta 7
London 7
Benin City 6
Bitola 6
Boston 6
Buffalo 6
Chennai 6
Frankfurt am Main 6
Haiphong 6
Seattle 6
Charlotte 5
Cusco 5
Da Nang 5
Houston 5
San Mateo 5
Assago 4
Detroit 4
Fort Worth 4
Jacksonville 4
Johannesburg 4
Katy 4
Lawrence 4
Mumbai 4
Philadelphia 4
Princeton 4
Riga 4
San Francisco 4
Tampa 4
The Bronx 4
Worcester 4
Buenos Aires 3
Converse 3
Falkenstein 3
Figino 3
Hải Dương 3
Medellín 3
Ninh Bình 3
Nuremberg 3
Olongapo City 3
Pasadena 3
Prilep 3
Prineville 3
Pune 3
Rabat 3
Redwood City 3
Springfield 3
Sydney 3
Tokyo 3
Toronto 3
Turin 3
Addis Ababa 2
Amman 2
Baku 2
Baltimore 2
Belo Horizonte 2
Bengaluru 2
Bien Hoa 2
Bogovinje 2
Bologna 2
Bridgetown 2
Camden 2
Chandigarh 2
Chicago 2
City of London 2
Claremont 2
Cuenca 2
Totale 2.077
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 225
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 145
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 97
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 90
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 78
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 77
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 76
Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration 75
Goodpasture syndrome and anti-glomerular basement membrane disease 75
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 74
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19 67
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 65
Renal sarcoidosis 65
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 64
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 62
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 61
Blood Thiol Redox State in Chronic Kidney Disease 60
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 60
Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016 59
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 58
Monoclonal gammopathy in lupus nephritis 57
Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells 57
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 56
Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients 54
Dysphagia screening post-stroke: systematic review 53
Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: an observational cohort study 52
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 52
Plasma protein carbonyls as biomarkers of oxidative stress in chronic kidney disease, dialysis, and transplantation 52
Anti-C1Q monitoring predicts relapses of lupus nephritis 52
Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis 52
Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis 51
HCV-negative mixed cryoglobulinemic glomerulonephritis and solid malignancy: A case report and review of the literature 49
Assessment of malnutrition risk in post-stroke patients: a systematic literature review 49
Enhancing clinical nutrition education for healthcare professionals: Engagement through active learning methodologies 48
Autophagy: A Silent Protagonist in Kidney Transplantation 48
Neurological Counterparts of Hyponatremia: Pathological Mechanisms and Clinical Manifestations 47
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 47
Renal involvement in eosinophilic granulomatosis with polyangiitis 46
Old and new calcineurin inhibitors in lupus nephritis 46
Preliminary experience on the use of sucrosomial iron in hemodialysis: focus on safety, hemoglobin maintenance and oxidative stress 45
Focal segmental glomerular sclerosis: do not overlook the role of immune response 45
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety 45
Integrated protocol for the prevention and treatment of skin ulcers in patients with end-stage renal disease 45
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 44
Hospital Malnutrition in the Medicine and Neurology Departments: A Complex Challenge 44
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons 43
Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety 42
Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients 40
Erdheim-Chester disease: From palliative care to targeted treatment 40
Plasma protein carbonylation in haemodialysed patients: Focus on diabetes and gender 39
Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra 38
Autophagy and podocytopathy 37
Kidney Involvement in Systemic Sclerosis 37
Immune-mediating and immunosuppressive pharmacotherapies for proliferative lupus nephritis 30
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 28
Predictors of Long-term Response in Patients With Lupus Nephritis 20
Pain, quality of life, work ability and psychosocial well-being in living kidney donors: A scoping review 19
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritis 18
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis 17
Diagnostic challenge of high vitamin B12 levels: a case report and review of the literature 12
Scaling up frailty: psychometric validation of the functional limitations and geriatric syndromes frailty questionnaire—a new tool for uniformly classifying vulnerable hospital patients 12
Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset 11
Malignancies in lupus nephritis: a retrospective cohort study on epidemiology and risk factors 11
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 9
Editorial: Exploring the impact of biologics in nephrology: clinical advances and future perspectives 8
Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis 5
Totale 3.385
Categoria #
all - tutte 19.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 1 1 3 0 0 1 3 1 4 11 1
2022/2023126 9 3 7 4 9 9 4 8 27 7 8 31
2023/2024464 38 12 69 48 20 47 61 44 17 9 40 59
2024/2025732 6 36 19 16 10 55 28 84 98 162 116 102
2025/20261.685 222 103 65 121 104 107 446 107 76 135 91 108
2026/2027301 162 139 0 0 0 0 0 0 0 0 0 0
Totale 3.385